Details of the Drug

General Information of Drug (ID: DMZHL2T)

• Drug Name: XmAB24306
• Synonyms: RG6323

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

• Drug Type: Recombinant protein
• Cross-matching ID:
  DrugBank ID: DB17526
  TTD ID: DIQE54

References

• [1] ClinicalTrials.gov (NCT04250155) An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors. U.S. National Institutes of Health.